Prosecution Insights
Last updated: August 06, 2026

Changde Jizhi Biological Technology Co. Ltd.

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
1
Medium (20%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only1 (20%)
§112 only1 (20%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WALKER, MARNITIA TRARESE 1
ARCORIA, PAUL JOSEPH 1
JONES-FOSTER, ERICA NICOLE 1 50.0% +47.5%
PRAKASH, SUBBALAKSHMI 1 45.1% +37.1%
BOECKELMAN, JACOB A 1 36.1% +46.1%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18582796 GEL FOR TREATING HEMORRHOIDS AND PREPARATION METHOD THEREOF WALKER, MARNITIA TRARESE
18534574 BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF JONES-FOSTER, ERICA NICOLE
18467745 MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF BOECKELMAN, JACOB A

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18534574 BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF JONES-FOSTER, ERICA NICOLE
18534570 TEA FOR WEIGHT LOSS AND LIPID-LOWERING AND PREPARATION METHOD THEREOF PRAKASH, SUBBALAKSHMI
18467745 MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF BOECKELMAN, JACOB A

Top Art Units

Art UnitApps
1655 2
1621 1
1656 1
1793 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18582796 GEL FOR TREATING HEMORRHOIDS AND PREPARATION METHOD THEREOF WALKER, MARNITIA TRARESE 1655 §103§112 Non-Final OA Pending Feb 21, 2024
18391872 COLD COMPRESS SPRAY FOR RELIEVING GOUT AND PREPARATION METHOD THEREOF ARCORIA, PAUL JOSEPH 1621 §103 Non-Final OA Pending Dec 21, 2023
18534574 BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF JONES-FOSTER, ERICA NICOLE 1656 §101§103§112 Non-Final OA Pending Dec 09, 2023
18534570 TEA FOR WEIGHT LOSS AND LIPID-LOWERING AND PREPARATION METHOD THEREOF PRAKASH, SUBBALAKSHMI 1793 §112 Non-Final OA Pending Dec 09, 2023
18467745 MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF BOECKELMAN, JACOB A 1655 §102§112 Final Rejection Pending Sep 15, 2023

Managing Changde Jizhi Biological Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month